We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+14.96%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$627M
AUM Growth
+$181M
(+41%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
20.82%
Top 10 Holdings %
Top 10 Hldgs %
46.99%
Holding
210
New
76
Increased
33
Reduced
30
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$17.7M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$9.51M |
| 3 |
Twilio
TWLO
|
+$7.81M |
| 4 |
STKL
SunOpta
STKL
|
+$7.64M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$10.6M |
| 2 |
Medifast
MED
|
+$9.84M |
| 3 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$9M |
| 4 |
First Solar
FSLR
|
+$8.39M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$7.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 12.05% |
| 4 | Consumer Discretionary | 6.3% |
| 5 | Consumer Staples | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
FTAI Aviation
FTAI
$20.3B
| $44.9M | 7.17% |
2,693,066
+85,249
| +3% | +$1.24M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $40.2M | 6.42% |
125,000
+121,000
| +3,025% | +$37.3M |
|
3
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
| $30.5M | 4.87% |
+1,150,000
| New | +$29.3M |
|
|
STKL
4
DELISTED
SunOpta
STKL
| $30.3M | 4.83% |
12,105,155
+3,431,670
| +40% | +$7.64M |
|
|
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $28M | 4.47% |
514,500
-149,950
| -23% | -$7.43M |
|
6
CALL
GE Aerospace
GE
$368B
| $26.8M | 4.27% |
481,528
+230,732
| +92% | +$11.9M |
|
|
EVA
7
DELISTED
Enviva Inc.
EVA
| $26.1M | 4.17% |
700,232
-31,010
| -4% | -$1.05M |
|
|
8
Guardant Health
GH
$20.2B
| $25.5M | 4.07% |
326,250
+246,250
| +308% | +$17.7M |
|
9
Alibaba
BABA
$279B
| $21.9M | 3.49% |
103,000
+22,750
| +28% | +$4.27M |
|
10
Microsoft
MSFT
$3.35T
| $20.3M | 3.23% |
128,500
+14,000
| +12% | +$2.06M |
|
11
Sunrun
RUN
$2.27B
| $18.7M | 2.98% |
1,351,500
+76,500
| +6% | +$1.14M |
|
12
Upland Software
UPLD
$13.6M
| $14.8M | 2.36% |
41,500
-500
| -1% | -$187K |
|
|
JE
13
DELISTED
Just Energy Group Inc
JE
| $14.8M | 2.36% |
268,030
+3,636
| +1% | +$261K |
|
14
Floor & Decor
FND
$5.98B
| $14M | 2.23% |
275,000
+52,500
| +24% | +$2.46M |
|
|
ZEN
15
DELISTED
ZENDESK INC
ZEN
| $13.3M | 2.12% |
173,000
+18,000
| +12% | +$1.32M |
|
|
PLAN
16
DELISTED
Anaplan, Inc.
PLAN
| $11.8M | 1.89% |
226,000
+55,000
| +32% | +$2.73M |
|
|
MBII
17
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $11.4M | 1.82% |
12,656,268
+874,326
| +7% | +$1.06M |
|
18
PUT
Invesco QQQ Trust
QQQ
$450B
| $10.6M | 1.7% |
+50,000
| New | +$10M |
|
19
STAAR Surgical
STAA
$1.21B
| $10.6M | 1.68% |
300,000
| – | – |
|
|
20
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $10.5M | 1.67% |
+110,000
| New | +$9.51M |
|
21
CALL
Bath & Body Works
BBWI
$4.02B
| $9.06M | 1.45% |
+618,500
| New | +$8.93M |
|
|
LHCG
22
DELISTED
LHC Group LLC
LHCG
| $8.27M | 1.32% |
+60,000
| New | +$7.47M |
|
|
WAAS
23
DELISTED
AquaVenture Holdings Limited
WAAS
| $8.14M | 1.3% |
300,000
-57,318
| -16% | -$1.22M |
|
|
24
Twilio
TWLO
$29B
| $7.51M | 1.2% |
+76,500
| New | +$7.81M |
|
25
Incyte
INCY
$24.9B
| $6.55M | 1.05% |
+75,000
| New | +$6.41M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
FWM
Ardsley Advisory Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Ardsley Advisory Partners held 210 positions worth $627M, up 41% from $446M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Ardsley Advisory Partners deployed $130M of net new capital in Q4 2019, opening 76 new positions and adding to 33 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Walt Disney, an estimated $10.6M trimmed.
- Ardsley Advisory Partners's largest Q4 2019 buy was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
- Ardsley Advisory Partners added most to Guardant Health in Q4 2019, an estimated $17.7M increase.
- Ardsley Advisory Partners's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $10.6M.
- Ardsley Advisory Partners fully exited Medifast in Q4 2019, selling an estimated $9.84M.
- Ardsley Advisory Partners's ten largest holdings make up 47% of its $627M portfolio in Q4 2019.
- Ardsley Advisory Partners opened 76 new positions and closed 60 in Q4 2019.
- Ardsley Advisory Partners's portfolio value rose 41% quarter-over-quarter to $627M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2019, filed 14 Feb 2020.